What does legacy reinsurance — operating expenses mean?

Represents the administrative and general overhead costs required to support the legacy reinsurance segment's operations. Tracking these expenses is essential for assessing the segment's overall cost structure and operational leverage.

King Pharmaceuticals KG Legacy Reinsurance — Operating Expenses

Similar metrics at other companies

EGLegacy — Other underwriting expenses

$65M-36.9%

TLegacy — Operating Expenses

$1.16B-14.3%

ACGLReinsurance — Other Operating Expenses

$117.25M+73.7%

EGReinsurance — Other Operating Expenses

$72.75M+0.3%

AXSReinsurance — Other operating expenses

$12.53M-0.8%

ACGLReinsurance — Other Expenses

$132M+3.9%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — operating expenses?: King Pharmaceuticals (KG) reported legacy reinsurance — operating expenses of $2.71M in Q1 2026.
What does legacy reinsurance — operating expenses mean?: Represents the administrative and general overhead costs required to support the legacy reinsurance segment's operations. Tracking these expenses is essential for assessing the segment's overall cost structure and operational leverage.